Healthcare -
Biotechnology - NASDAQ - US
$ 5.44
2.84 %
$ 350 M
Market Cap
-5.49
P/E
CRVS - CHANGE IN WORKING CAPITAL
Change in Working Capital CRVS - Corvus Pharmaceuticals, Inc.
-3.59 M
LAST VALUE
-5.39%
2 YEAR CAGR
-20.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR